Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» cancer immunotherapy
cancer immunotherapy
Janssen returns rights for experimental cancer immunotherapy to Alligator Bioscience, sending shares spiraling by 40%
Pharmaceutical Business Review
Fri, 08/2/19 - 11:48 pm
Janssen
Alligator Biosciences
CD40
cancer immunotherapy
Merck Bags Tilos, Adding an Immunotherapy Booster to Its Arsenal
Xconomy
Mon, 06/10/19 - 09:41 am
Merck
M&A
Tilos Therapeutics
cancer immunotherapy
oncology
Despite research boom, few immunotherapy studies targeting pancreatic cancer
Biopharma Dive
Mon, 04/1/19 - 12:18 pm
pancreatic cancer
cancer immunotherapy
AACR
Bristol-Myers Squibb
Merck
Apexigen
Sanofi invests €80M in BioNTech as cancer mRNA hits clinic
Fierce Biotech
Sat, 01/5/19 - 01:30 pm
Sanofi
BioNTech
MRNA
cancer immunotherapy
Astellas gains three cancer drugs with $405m Potenza buy
Pharmaforum
Fri, 12/14/18 - 12:47 pm
Astellas
Potenza Therapeutics
M&A
cancer immunotherapy
AZ begins liver cancer immunotherapy tie-up with AVEO
Pharmaforum
Thu, 12/13/18 - 10:29 am
AstraZeneca
Aveo Oncology
cancer immunotherapy
Imfinzi
Fotivda
hepatocellular carcinoma
Eli Lilly Commits $40M to NextCure in Hunt for New Cancer Drugs
Xconomy
Mon, 11/5/18 - 07:19 pm
Eli Lilly
NextCure
cancer immunotherapy
drug development
Gilead Sciences and Tango Therapeutics Form Partnership Worth Up to $1.7 Billion to Develop Next-Gen Immuno-Oncology Therapies
CP Wire
Wed, 10/31/18 - 12:02 pm
Gilead Sciences
Tango Therapeutics
cancer immunotherapy
Gilead Sciences and Tango Therapeutics Form Partnership Worth Up to $1.7 Billion to Develop Next-Gen Immuno-Oncology Therapies
Wed, 10/31/18 - 12:00 pm
Gilead Sciences
Tango Therapeutics
cancer immunotherapy
Merck KGaA’s bold new approach to cancer immunotherapy
Pharmaforum
Mon, 10/29/18 - 11:35 pm
Merck KGaA
cancer immunotherapy
M7824
Affimed and Roche ink $5bn plus cancer immunotherapy deal
Pharmaforum
Tue, 08/28/18 - 10:03 am
Roche
Genentech
Affimed
cancer immunotherapy
drug development
AbbVie doubles down on cancer project with biotech group Argenx
Yahoo/Reuters
Wed, 08/22/18 - 09:49 am
Argenx
AbbVie
ARGX-115
cancer immunotherapy
Genmab puts down $54M for immunotherapy collaboration — ready to spend millions more
Endpoints
Thu, 07/12/18 - 06:27 pm
Genmab
JNJ
Europe
cancer immunotherapy
Immatics
Immunotherapy advances spur new look at cancer vaccines
Biopharma Dive
Mon, 06/25/18 - 09:10 pm
cancer immunotherapy
cancer vaccines
vaccines
Incyte study could bring lessons for cancer immunotherapy
Biopharma Dive
Wed, 03/14/18 - 11:27 am
Incyte
cancer immunotherapy
metastatic melanoma
Merck
Keytruda
3 Ways AI Is Changing Medicine
Motley Fool
Thu, 09/21/17 - 08:30 am
artificial intelligence
Gritstone Oncology
Alphabet
cancer immunotherapy
IBM Watson
Pfizer
Google Brain
diabetes
retinal blindness
HeartFlow
Verily
A small drug company that's trying to make cancer treatments safer just received a $3.8 billion endorsement
Yahoo/Business Insider
Mon, 03/20/17 - 11:01 pm
CytomX
cancer immunotherapy
Bristol-Myers Squibb
Here’s the silver lining inside today’s trial fail for Bristol-Myers' cancer drug
Bizjournals.com
Sat, 08/6/16 - 12:51 pm
Bristol-Myers Squibb
Opdivo
cancer immunotherapy
Adaptimmune gets a partial hold on pivotal T-cell study, but it seems OK to breathe now
Endpoints
Thu, 08/4/16 - 09:56 am
Adaptimmune
T-cells
myxoid round cell liposarcoma
CAR-T
cancer immunotherapy
Regeneron leaps into the blockbuster race to develop off-the-shelf immune cell cancer therapies
Endpoints
Tue, 08/2/16 - 09:00 am
Regeneron
drug development
CAR-T
cancer immunotherapy
Adicet Bio
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »